Evidence map›Paper›PMID 30150729›Full record

ArticleScientific reports2018

Effect of Tobacco Smoking Cessation on C-Reactive Protein Levels in A Cohort of Low-Dose Computed Tomography Screening Participants.

Silvano Gallus, Alessandra Lugo, Paola Suatoni, Francesca Taverna, Elena Bertocchi, Roberto Boffi, Alfonso Marchiano, Daniele Morelli, Ugo Pastorino

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05766046 (Early Diagnosis of Lung Cancer of the Italian Pulmonary Screening Network), which is not on this map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05766046 naactive not recruitingnot on this mapstarted 2022, after this paper: background citation

Early Diagnosis of Lung Cancer of the Italian Pulmonary Screening Network (RISP): Comparative Analysis for the Use of Low Dose Computed Tomography and Promotion of Primary Prevention Interventions in Subjects at High Risk for Lung Cancer

TypeinterventionalSponsorUgo PastorinoRan2022 to 2026Enrolled7,324ConditionsLung Cancer, COPD (Chronic Obstructive Pulmonary Disease) With Acute Lower Respiratory Infection, Cardiovascular DiseasesArmsearly lung cancer detection, blood test
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Silvano GallusDepartment of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. silvano.gallus@marionegri.it.
Alessandra LugoDepartment of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Paola SuatoniThoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Francesca TavernaImmunohematology & Transfusion Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Elena BertocchiThoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Roberto BoffiTobacco Control Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Alfonso MarchianoDepartment of Radiology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Daniele MorelliLaboratory Medicine Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.ORCID 0000-0002-1823-3764
Ugo PastorinoThoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Fondazione IRCCS Istituto Nazionale dei Tumori · ITMario Negri Institute for Pharmacological Research · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Smokers have higher levels of C-Reactive Protein (CRP) compared to never smokers. The role of smoking cessation on CRP is still under debate. Using data from two screening studies conducted in Italy in 2000-2010 on 3050 heavy smokers (including 777 ex-smokers), we estimated multivariate odds ratios (OR) for high CRP (i.e. ≥2 mg/L) according to smoking status. Moreover, in a longitudinal analysis based on 975 current smokers, with a second measurement of CRP after an average study period of 3.4 years, we estimated the changes in CRP according to smoking cessation. Prevalence of high CRP at baseline was 35.8% among ex-smokers and 41.1% among current smokers (significant OR for ex- vs. current smokers: 0.79). After four years since smoking cessation, CRP levels significantly decreased with increasing years of cessation (significant OR for ex-smokers since more than 8 years: 0.55). In the longitudinal analysis, no significant reduction in CRP was found for time since smoking cessation (ORs: 1.21, 1.04, and 0.91 for ex-smokers since 1 year, 2-3 years, and ≥4 years, respectively). In the largest prospective study available so far, we found that smoking cessation has a favourable effect on CRP, but this benefit is not evident in the short-term.

Indexed as

Smoking CessationC-Reactive ProteinFemaleHumansLongitudinal StudiesMaleMiddle AgedOdds RatioTomography, X-Ray ComputedC-Reactive Protein

Identifiers

PMID30150729
PMCPMC6110802
OpenAlexW2888261336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.